Table 2.
The Clinical and Laboratory Findings in Children for MIS-C
| Children (n = 45) | N (%) |
|---|---|
| COVID-19 testing | |
| RT-PCR-/serology+ | 43 (96%) |
| BOS serology+ | 2 (5%) |
| RT-PCR+/serology+ | 2 (4%) |
| Sign and symptoms | |
| General | |
| Fever | 42 (93%) |
| Weakness | 40 (89%) |
| Rash | 15 (33%) |
| Conjunctivitis | 3 (7%) |
| Thorax | |
| Cough | 9 (20%) |
| Respiratory distress | 9 (20%) |
| Cardiac | |
| Myocardial dysfunction | 14 (31%) |
| Abdomen | |
| Abdominal pain | 28 (62%) |
| Vomiting | 20 (44%) |
| Central nervous system | |
| Seizure | 14 (31%) |
| Neck stiffness | 6 (13%) |
| Inability to walk | 1 (2%) |